Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » SARS-CoV-2 Introduced Into UK More Than 1,000 Times Early in Pandemic, Study Finds

SARS-CoV-2 Introduced Into UK More Than 1,000 Times Early in Pandemic, Study Finds

Jan 08, 2021
|
staff reporter

NEW YORK – SARS-CoV-2 was introduced into the UK more than a thousand times at the start of the COVID-19 pandemic, according to a new analysis.

By analyzing more than 50,000 SARS-CoV-2 genomes, about half of which were collected in the UK, in conjunction with travel and epidemiological data, a University of Oxford-led team of researchers examined the origins and spread of SARS-CoV-2 in the UK. The initial wave of the pandemic peaked there in April 2020, and by late June nearly 40,500 COVID-19-related deaths were reported in the UK. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

Jan
28
Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Feb
11
Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb
17
Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Sponsored by
BioLegend

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb
18
Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

What's Popular?

In Sequencing

  1. Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

    Premium

  2. Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

  3. Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease

    Premium

  4. Sano Genetics Raises £2.5M in Private Seed Funding

  5. Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.